O Grip1, S Janciauskiene, S Lindgren. 1. Department of Medicine, Lund University, University Hospital MAS, Malmö, Sweden. olof.grip@medforsk.mas.lu.se
Abstract
OBJECTIVE: To investigate the ability of statins to activate the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-gamma) in primary human monocytes in culture. MATERIALS AND METHODS: Human peripheral monocytes were incubated with atorvastatin (0.1-10 micromol/1) for up to 24 hours. PPAR-gamma expression was analysed by electrophoretic mobility shift assay. Pro-inflammatory cytokines were measured by enzyme-linked immunosorbent assays, and oxygen consumption was determined polarographically with a Clark-type oxygen electrode. RESULTS: We found that atorvastatin activates PPAR-gamma and inhibits the production of tumour necrosis factor-alpha up to 38% (p < 0.05), monocyte chemoattractant protein-1 up to 85% (p < 0.05), and gelatinase B up to 73% (p < 0.05), in a concentration-dependent manner. Moreover, atorvastatin shows concentration-dependent inhibition of cellular oxygen consumption up to 41%. CONCLUSIONS: These findings contribute to the growing knowledge of the anti-inflammatory effects of statins, and have led us to the suggestion that statins may control inflammatory responses by the regulation of intracellular lipid homeostasis.
OBJECTIVE: To investigate the ability of statins to activate the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-gamma) in primary human monocytes in culture. MATERIALS AND METHODS:Human peripheral monocytes were incubated with atorvastatin (0.1-10 micromol/1) for up to 24 hours. PPAR-gamma expression was analysed by electrophoretic mobility shift assay. Pro-inflammatory cytokines were measured by enzyme-linked immunosorbent assays, and oxygen consumption was determined polarographically with a Clark-type oxygen electrode. RESULTS: We found that atorvastatin activates PPAR-gamma and inhibits the production of tumour necrosis factor-alpha up to 38% (p < 0.05), monocyte chemoattractant protein-1 up to 85% (p < 0.05), and gelatinase B up to 73% (p < 0.05), in a concentration-dependent manner. Moreover, atorvastatin shows concentration-dependent inhibition of cellular oxygen consumption up to 41%. CONCLUSIONS: These findings contribute to the growing knowledge of the anti-inflammatory effects of statins, and have led us to the suggestion that statins may control inflammatory responses by the regulation of intracellular lipid homeostasis.
Authors: J T Huang; J S Welch; M Ricote; C J Binder; T M Willson; C Kelly; J L Witztum; C D Funk; D Conrad; C K Glass Journal: Nature Date: 1999-07-22 Impact factor: 49.962
Authors: A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz Journal: Mol Cell Date: 2001-01 Impact factor: 17.970
Authors: Brian M Fuller; Mithil Gajera; Christa Schorr; David Gerber; R Phillip Dellinger; Sergio Zanotti Journal: Eur J Emerg Med Date: 2012-08 Impact factor: 2.799
Authors: C F Araujo-Lima; R B Peres; P B Silva; M M Batista; C A F Aiub; I Felzenszwalb; M N C Soeiro Journal: Antimicrob Agents Chemother Date: 2018-08-27 Impact factor: 5.191
Authors: J Kowalski; B Okopień; A Madej; M Zieliński; D Belowski; Z Kalina; Z S Herman Journal: Eur J Clin Pharmacol Date: 2003-05-17 Impact factor: 2.953